Fundz

General Oncology reported raising $4.81 Million in an initial SEC Form D filing, from an offering of $4.81 Million

PRIVATEApr 23, 2026

Amount Raised

$4.81 Million

$4.81 Million sold, per SEC Form D (first sale Apr 15, 2026)

Round Type

Venture

BrooklineBiotechnologyHealthcare

Quick answer

General Oncology raised $4.81 Million in a funding round, dated April 15, 2026. General Oncology is based in Brookline, Massachusetts, United States.

How much did General Oncology raise?
General Oncology raised $4.81 Million in a funding round on April 15, 2026.
What does General Oncology do?
General Oncology is a clinical-stage biopharmaceutical company dedicated to pioneering first-in-class medicines for metastatic cancers.
Where is General Oncology based and how big is it?
General Oncology is based in Brookline, Massachusetts, United States. Fundz records about 6 employees.
Who are the decision-makers at General Oncology?
Fundz holds 1 contact at General Oncology, including the VP of Medicinal Chemistry. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Healthcare and Biotechnology around the same time

Companies in the same sectors as General Oncology that raised within 45 days of this round, from Fundz verified event records.

  • Tempest Therapeutics raised $4.1M on May 29, 2026.
  • Lakewood-Amedex, Inc. raised $7.5M (Series C) on May 22, 2026.
  • AIM ImmunoTech raised $2.4M (Post-IPO Equity) on May 20, 2026.
  • IRulya Therapeutics Inc. raised $115M on May 18, 2026.
  • iSpecimen raised $5M (Post-IPO Equity) on May 11, 2026.
  • Kanvas Biosciences raised $48M (Series A) on May 6, 2026.

Who to call at General Oncology, and when

A new round usually means General Oncology is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day General Oncology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at General Oncology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at General Oncology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

General Oncology

Location

Brookline, Massachusetts, United States

About

General Oncology is a clinical-stage biopharmaceutical company dedicated to pioneering first-in-class medicines for metastatic cancers.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment General Oncology raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsHongbo D., VP of Medicinal Chemistry hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for General Oncology's next move

See what Strategic adds

General Oncology raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.